Motley Fool Asset Management »

Neurocrine Biosciences shares owned by Motley Fool Asset Management

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Motley Fool Asset Management from 13F filings

Historical chart of Motley Fool Asset Management investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Motley Fool Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Motley Fool Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $246k 1.9k 131.76
2023-09-30 $229k 2.0k 112.50
2022-12-31 $206k 1.7k 119.44
2021-12-31 $4.0k 44 90.91

More positions owned by Motley Fool Asset Management

Apple Ordinary Shares (AAPL)
Microsoft Corp Ordinary Shares (MSFT)
Amazon Ordinary Shares (AMZN)
Alphabet Inc Cl C Ordinary Shares (GOOG)
Watsco Ordinary Shares (WSO)
Axon Enterprise Ordinary Shares (AXON)
Nvidia Corp Ordinary Shares (NVDA)
Mastercard Ordinary Shares (MA)
Meta Platforms Ordinary Shares (META)
Icon American Depository Receipts (ICLR)
Tesla Ordinary Shares (TSLA)
Berkshire Hathaway Inc Cl B Ordinary Shares (BRK.B)
Costco Whsl Corp Ordinary Shares (COST)
Salesforce Ordinary Shares (CRM)
Fastenal Ordinary Shares (FAST)

View all positions for Motley Fool Asset Management

Top funds holding Neurocrine Biosciences

Vanguard Group
Bellevue Group
Jpmorgan Chase & Co
Henderson Group
T. Rowe Price Associates
Point72 Asset Management
Dodge & Cox
DSM Capital Partners
Wellington Management Company
Brown Advisory Holdings Incorporated
Bank of New York Mellon
Deerfield Management Company
Franklin Resources
Jacobs Levy Equity Management
AQR Capital Management

View all funds holding Neurocrine Biosciences